Predictive Oncology (NASDAQ: POAI), a data and
artificial-intelligence- (“AI”) driven, discovery-services company, possesses a
unique advantage over its competition in the form of samples and access to
historical data on clinical outcomes. This data could enable POAI to produce
value to pharmaceutical companies significantly faster than its competitors. An
article discussing the company reads, “Specifically, POAI can leverage two
unique proprietary assets, from its acquisition of Helomics, which virtually
eliminate development risk, a factor that considerably weighs on competitors’
efforts in the precision medicine space. First, Predictive Oncology possesses a
clinically validated, tumor-profiling platform built from data derived from
actual tumors collected from patients over more than 10 years, which was
clinically validated in ovarian cancer. Second, the company possesses data on
the drug-response profiles of over 150,000 tumors across 137 cancer types
tested over the same period. Using this valuable historical data, POAI’s
platform can help predict drug response and outcome of the specific type of
tumor collected from new patients, thus improving the patient outcomes.”
To view the full article, visit http://ibn.fm/lMTkW
About Predictive Oncology
POAI is bringing precision medicine, or tailored medical
treatment using the individual characteristics of each patient, to the
treatment of cancer. Through its Helomics division, the company leverages its
unique, clinically validated patient-derived (PDx) smart tumor-profiling
platform to provide oncologists with a road map to help individualize therapy.
In addition, the company is leveraging artificial intelligence and its
proprietary database of over 150,000 cancer cases to build AI-driven models of
tumor drug response to improve outcomes for the patients of today and tomorrow.
For more information, visit the company’s website at www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates
relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment